Who Exports Tobramycin from India — 283 Suppliers Behind a $39.2M Market

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical ecosystem is bolstered by a robust infrastructure, skilled workforce, and supportive government policies. Companies like Mylan Laboratories Limited, a significant exporter of Tobramycin with exports totaling $2.8 million (7.2% of total exports), have established substantial operations in this region. Hyderabad's focus on API manufacturing makes it a pivotal player in the global supply chain for antibiotics like Tobramycin.

The Ahmedabad-Vadodara corridor in Gujarat is a prominent hub for pharmaceutical formulations. This region hosts major companies such as Sun Pharmaceutical Industries Limited, which exported Tobramycin worth $6.4 million (16.2% of total exports). The area's emphasis on finished dosage forms, coupled with advanced manufacturing facilities and a strong regulatory framework, positions it as a key contributor to India's pharmaceutical exports.

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. This region's proximity to major ports facilitates efficient international distribution. Companies like Gland Pharma Limited, with Tobramycin exports amounting to $3.4 million (8.6% of total exports), leverage this strategic location to enhance their global reach. The area's well-developed logistics and regulatory compliance make it an attractive base for pharmaceutical exporters.

Baddi-Nalagarh in Himachal Pradesh is known for its favorable tax incentives, attracting numerous pharmaceutical manufacturers. Mankind Pharma Limited, the leading exporter of Tobramycin with exports totaling $8.1 million (20.7% of total exports), operates multiple manufacturing units in this region. The company's facilities in Paonta Sahib focus on various dosage forms, including injectables and oral solids, adhering to stringent international quality standards.

• Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing Tobramycin from multiple manufacturers across different clusters, such as Mankind Pharma in Baddi-Nalagarh and Sun Pharmaceutical in Ahmedabad-Vadodara.

• Evaluate Manufacturing Capabilities: Assess the specific manufacturing capabilities of potential suppliers. For instance, Mankind Pharma's Unit I in Paonta Sahib specializes in injectables, which may align with specific formulation requirements.

• Ensure Regulatory Compliance: Verify that suppliers comply with international regulatory standards. Facilities like Mankind Pharma's Unit III are USFDA-approved, ensuring adherence to stringent quality protocols.

• Leverage Export Infrastructure: Utilize suppliers located in regions with robust export infrastructure, such as the Mumbai-Thane-Raigad belt, to facilitate efficient international distribution of Tobramycin.

By strategically selecting suppliers from these key pharmaceutical clusters, companies can enhance the reliability and efficiency of their Tobramycin supply chain.